Pharsight

Eugia Pharma Speclts patents expiration

1. Cyclophosphamide patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9662342 EUGIA PHARMA SPECLTS Formulations of cyclophosphamide liquid concentrate
Jun, 2035

(11 years from now)

Drugs and Companies using CYCLOPHOSPHAMIDE ingredient

Market Authorisation Date: 25 August, 2021

Treatment: NA

Dosage: SOLUTION;INTRAVENOUS

How can I launch a generic of CYCLOPHOSPHAMIDE before it's drug patent expiration?
More Information on Dosage

CYCLOPHOSPHAMIDE family patents

Family Patents